A clinical trial led by Kirby Institute at UNSW Sydney has found that point-of-care testing for hepatitis B DNA is as ...
Subvisible particle testing addresses regulatory limits for particulate matter in parenteral drugs, ophthalmic solutions, and lipid emulsions.
A clinical trial has found that point-of-care testing for hepatitis B DNA is as effective as traditional laboratory testing, ...
Experts estimate that over 13,000 new cervical cancer diagnoses occurred in the United States in 2025, accompanied by over ...
A new study in "Nature Medicine" estimates 2 million people are incorrectly told they have TB each year — and clinicians miss ...
BillionToOne Expands Its Leadership in Hemolytic Disease of the Fetus and Newborn (HDFN) and Extends Fetal Antigen Testing to Fetal and Neonatal Alloimmune Thrombocytopenia (FNAIT) ...
The Grand Forks-East Metropolitan Planning Organization is looking ahead to what the greater area's population may be in 30 years, and how that might ...
The muted sequential outlook comes as EPS estimates have fallen 15% over the past two months, signaling growing caution among analysts. Revenue estimates have held largely steady over the same period, ...
You walk through a field of wheat, ryegrass, or clover and notice the sway of stems and leaves. What you cannot see is where most of the action happens.
Google shared how its Gemini AI can help users plan budgets, track spending, and identify savings using simple prompts.
On February 5, 2025, Jerash's Board of Directors approved a regular quarterly dividend of $0.05 per share on its common stock payable on February 25, 2025, to stockholders of record as of February 18, ...
Aventis Energy Inc. ('Aventis” or the 'Company”) (CSE: AVE | FRA: C0O | OTC: VBAMF), is pleased to announce that mobilization ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results